Sphera Funds Management Ltd. Neu Base Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$4.63 - $7.34 $147,697 - $234,146	-31,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.92 - $12.36 $220,748 - $394,284	31,900 New	31,900 $236,000
Q4 2020 Feb 16, 2021	SELL	$6.92 - $9.25 $1.04 Million - $1.39 Million	-150,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.69 - $11.51 $1 Million - $1.73 Million	150,000 New	150,000 $1.32 Million

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.